Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q8TB61
UPID:
S35B2_HUMAN
Alternative names:
PAPS transporter 1; Putative MAPK-activating protein PM15; Putative NF-kappa-B-activating protein 48; Solute carrier family 35 member B2
Alternative UPACC:
Q8TB61; B4DDM2; B4DDU9; F5H7Y9; Q2VY06; Q53GA3; Q5T9W1; Q5T9W2; Q7Z2G3; Q8NBK6; Q96AR6
Background:
Adenosine 3'-phospho 5'-phosphosulfate transporter 1, also known as PAPS transporter 1, plays a crucial role in cellular processes by functioning as a 3'-phosphoadenylyl sulfate:adenosine 3',5'-bisphosphate antiporter at the Golgi membranes. This protein facilitates the transport of 3'-phosphoadenylyl sulfate/adenosine 3'-phospho 5'-phosphosulfate (PAPS) into the Golgi lumen, a key step in sulfation events.
Therapeutic significance:
Given its involvement in hypomyelinating leukodystrophy 26, with chondrodysplasia, understanding the role of Adenosine 3'-phospho 5'-phosphosulfate transporter 1 could open doors to potential therapeutic strategies for treating this severe neurological disorder.